Document
falsefalse--12-31--12-31Q1Q1201920192019-03-3110-Q00015745400001583994falsefalseLarge Accelerated FilerNon-accelerated FilerfalsefalseP1Y10.015000000001824160071843079101824160071843079100.007750.00850.0090.010.0110.01250.008250.0090.01450.01650.0110.0110.0125850000000750000001500000003500000004000000002500000000.04240.04740.04090.04030.03950.0430.023218241600718430791018241600718430791000518278451782915182784517829186000001800000P3YP2Y
0001574540
2019-01-01
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
2019-01-01
2019-03-31
0001574540
2019-04-24
0001574540
2019-03-31
0001574540
2018-12-31
0001574540
2018-01-01
2018-03-31
0001574540
us-gaap:RetainedEarningsMember
2019-01-01
2019-03-31
0001574540
us-gaap:NoncontrollingInterestMember
2018-12-31
0001574540
us-gaap:CommonStockMember
2019-01-01
2019-03-31
0001574540
us-gaap:AdditionalPaidInCapitalMember
2018-12-31
0001574540
2019-01-01
0001574540
us-gaap:AdditionalPaidInCapitalMember
2019-01-01
2019-03-31
0001574540
us-gaap:CommonStockMember
2018-12-31
0001574540
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2019-01-01
2019-03-31
0001574540
us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember
2019-03-31
0001574540
us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember
2019-01-01
2019-03-31
0001574540
us-gaap:ParentMember
2019-01-01
2019-03-31
0001574540
us-gaap:ParentMember
2019-01-01
0001574540
doc:OperatingPartnershipNoncontrollingInterestMember
2019-01-01
2019-03-31
0001574540
us-gaap:CommonStockMember
2019-03-31
0001574540
us-gaap:AdditionalPaidInCapitalMember
2019-01-01
0001574540
us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember
2018-12-31
0001574540
us-gaap:AdditionalPaidInCapitalMember
2019-03-31
0001574540
us-gaap:NoncontrollingInterestMember
2019-01-01
2019-03-31
0001574540
us-gaap:ParentMember
2019-03-31
0001574540
us-gaap:RetainedEarningsMember
2019-03-31
0001574540
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2018-12-31
0001574540
us-gaap:ParentMember
2018-12-31
0001574540
us-gaap:NoncontrollingInterestMember
2019-03-31
0001574540
doc:OperatingPartnershipNoncontrollingInterestMember
2018-12-31
0001574540
doc:OperatingPartnershipNoncontrollingInterestMember
2019-03-31
0001574540
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2019-03-31
0001574540
us-gaap:RetainedEarningsMember
2018-12-31
0001574540
2018-03-31
0001574540
us-gaap:ParentMember
2018-01-01
2018-03-31
0001574540
doc:OperatingPartnershipNoncontrollingInterestMember
2018-01-01
2018-03-31
0001574540
us-gaap:NoncontrollingInterestMember
2017-12-31
0001574540
us-gaap:NoncontrollingInterestMember
2018-01-01
2018-03-31
0001574540
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2018-01-01
2018-03-31
0001574540
doc:OperatingPartnershipNoncontrollingInterestMember
2018-03-31
0001574540
us-gaap:RetainedEarningsMember
2018-01-01
2018-03-31
0001574540
us-gaap:AdditionalPaidInCapitalMember
2018-01-01
2018-03-31
0001574540
us-gaap:CommonStockMember
2018-01-01
2018-03-31
0001574540
us-gaap:CommonStockMember
2017-12-31
0001574540
us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember
2017-12-31
0001574540
2017-12-31
0001574540
us-gaap:RetainedEarningsMember
2018-03-31
0001574540
us-gaap:RetainedEarningsMember
2017-12-31
0001574540
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2017-12-31
0001574540
us-gaap:ParentMember
2018-03-31
0001574540
us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember
2018-03-31
0001574540
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2018-03-31
0001574540
doc:OperatingPartnershipNoncontrollingInterestMember
2017-12-31
0001574540
us-gaap:ParentMember
2017-12-31
0001574540
us-gaap:AdditionalPaidInCapitalMember
2017-12-31
0001574540
us-gaap:AdditionalPaidInCapitalMember
2018-03-31
0001574540
us-gaap:CommonStockMember
2018-03-31
0001574540
us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember
2018-01-01
2018-03-31
0001574540
us-gaap:NoncontrollingInterestMember
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
2018-12-31
0001574540
doc:PhysiciansRealtyLPMember
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
2018-01-01
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
2019-01-01
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:LimitedPartnerMember
2018-12-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:LimitedPartnerMember
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:GeneralPartnerMember
2019-01-01
0001574540
doc:PhysiciansRealtyLPMember
doc:PartnersCapitalMember
2019-01-01
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:LimitedPartnerMember
2019-01-01
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-12-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:GeneralPartnerMember
2019-01-01
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:GeneralPartnerMember
2018-12-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:GeneralPartnerMember
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2019-01-01
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
doc:PartnersCapitalMember
2018-12-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
doc:PartnersCapitalMember
2019-01-01
0001574540
doc:PhysiciansRealtyLPMember
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2018-12-31
0001574540
doc:PhysiciansRealtyLPMember
doc:PartnersCapitalMember
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
doc:PartnersCapitalMember
2018-01-01
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:GeneralPartnerMember
2018-01-01
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2018-01-01
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2017-12-31
0001574540
doc:PhysiciansRealtyLPMember
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2017-12-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:LimitedPartnerMember
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
doc:PartnersCapitalMember
2017-12-31
0001574540
doc:PhysiciansRealtyLPMember
doc:PartnersCapitalMember
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:LimitedPartnerMember
2017-12-31
0001574540
doc:PhysiciansRealtyLPMember
2017-12-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:LimitedPartnerMember
2018-01-01
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:GeneralPartnerMember
2017-12-31
0001574540
doc:PhysiciansRealtyLPMember
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:GeneralPartnerMember
2018-03-31
0001574540
doc:A2016ATMProgramMember
srt:MaximumMember
us-gaap:PrivatePlacementMember
2016-08-05
2016-08-05
0001574540
doc:PhysiciansRealtyLPMember
doc:A2016ATMProgramMember
us-gaap:PrivatePlacementMember
2019-01-01
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
doc:A2016ATMProgramMember
us-gaap:SubsequentEventMember
us-gaap:PrivatePlacementMember
2019-04-24
0001574540
doc:HealthEastClinicSpecialtyCenterMember
2019-03-31
0001574540
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
2019-03-31
0001574540
doc:HealthEastClinicSpecialtyCenterMember
2019-01-09
0001574540
doc:MezzanineLoanReceivableMember
2019-03-31
0001574540
us-gaap:ConstructionLoansMember
2019-03-31
0001574540
2018-01-09
2018-01-09
0001574540
us-gaap:AccountingStandardsUpdate201602Member
2019-01-01
0001574540
us-gaap:SeriesAPreferredStockMember
2015-02-05
0001574540
us-gaap:SeriesAPreferredStockMember
2015-02-05
2015-02-05
0001574540
doc:PhysiciansRealtyTrustMember
2019-01-01
2019-03-31
0001574540
doc:HealthEastClinicSpecialtyCenterMember
2019-01-01
2019-03-31
0001574540
doc:TermLoanReceivableMember
2019-03-31
0001574540
2019-03-22
2019-03-22
0001574540
us-gaap:LeasesAcquiredInPlaceMember
2019-03-31
0001574540
doc:TermLoanMember
2019-01-01
2019-03-31
0001574540
us-gaap:RealEstateLoanMember
2019-03-31
0001574540
doc:TermLoanMember
2019-03-31
0001574540
doc:AcquiredLeaseIntangiblesMember
2019-03-31
0001574540
us-gaap:BuildingAndBuildingImprovementsMember
2019-03-31
0001574540
us-gaap:LandAndLandImprovementsMember
2019-03-31
0001574540
us-gaap:OtherAssetsMember
2019-03-31
0001574540
us-gaap:LeasesAcquiredInPlaceMember
2019-01-01
2019-03-31
0001574540
doc:BelowMarketLeasesMember
2018-01-01
2018-03-31
0001574540
us-gaap:AboveMarketLeasesMember
2018-01-01
2018-03-31
0001574540
doc:BelowMarketGroundLeaseMember
2018-01-01
2018-03-31
0001574540
doc:BelowMarketLeasesMember
2019-01-01
2019-03-31
0001574540
us-gaap:AboveMarketLeasesMember
2019-01-01
2019-03-31
0001574540
doc:BelowMarketGroundLeaseMember
2019-01-01
2019-03-31
0001574540
doc:LeaseholdInterestMember
2019-01-01
2019-03-31
0001574540
doc:AboveMarketGroundLeaseMember
2018-01-01
2018-03-31
0001574540
us-gaap:LeasesAcquiredInPlaceMember
2018-01-01
2018-03-31
0001574540
doc:AboveMarketGroundLeaseMember
2019-01-01
2019-03-31
0001574540
doc:LeaseholdInterestMember
2018-01-01
2018-03-31
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
2019-01-01
2019-03-31
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
2019-01-01
2019-03-31
0001574540
doc:BelowMarketGroundLeaseMember
2019-03-31
0001574540
doc:BelowMarketLeasesMember
2019-03-31
0001574540
doc:LeaseholdInterestMember
2018-12-31
0001574540
us-gaap:AboveMarketLeasesMember
2019-03-31
0001574540
us-gaap:AboveMarketLeasesMember
2018-12-31
0001574540
doc:BelowMarketLeasesMember
2018-12-31
0001574540
doc:OperatingLeaseRightofUseAssetsMember
2018-12-31
0001574540
doc:AboveMarketGroundLeaseMember
2019-03-31
0001574540
doc:BelowMarketGroundLeaseMember
2018-12-31
0001574540
doc:OperatingLeaseRightofUseAssetsMember
2019-03-31
0001574540
doc:LeaseholdInterestMember
2019-03-31
0001574540
us-gaap:LeasesAcquiredInPlaceMember
2018-12-31
0001574540
doc:AboveMarketGroundLeaseMember
2018-12-31
0001574540
doc:CreditratingbelowBBBorBAA3Member
doc:BaseRateLoansMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:BaseRateMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastBBBorBAA3Member
doc:BaseRateLoansMember
doc:TermLoanMember
us-gaap:BaseRateMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastBBBorBAA2Member
doc:BaseRateLoansMember
doc:TermLoanMember
us-gaap:BaseRateMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastBBBplusorBAA1Member
doc:BaseRateLoansMember
doc:TermLoanMember
us-gaap:BaseRateMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastBBBplusorBAA1Member
doc:BaseRateLoansMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:BaseRateMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastBBBorBAA3Member
doc:BaseRateLoansMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:BaseRateMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastAorA3Member
doc:BaseRateLoansMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:BaseRateMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastAorA3Member
doc:BaseRateLoansMember
doc:TermLoanMember
us-gaap:BaseRateMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingbelowBBBorBAA3Member
doc:BaseRateLoansMember
doc:TermLoanMember
us-gaap:BaseRateMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastBBBorBAA2Member
doc:BaseRateLoansMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:BaseRateMember
2019-01-01
2019-03-31
0001574540
doc:UnsecuredNotesBearingFixedInterestDueMarch2027Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
doc:UnsecuredTermLoanDueJune2023Member
us-gaap:UnsecuredDebtMember
2018-12-31
0001574540
doc:MortgageNotesBearingVariableInterestDue2028Member
us-gaap:MortgagesMember
2018-12-31
0001574540
doc:SeniorUnsecuredNotesDueAugust2025to2027Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
doc:UnsecuredNotesBearingFixedInterestDueMarch2027Member
us-gaap:SeniorNotesMember
2018-12-31
0001574540
doc:UnsecuredNotesBearingFixedInterestDueJanuary2028Member
us-gaap:SeniorNotesMember
2018-12-31
0001574540
doc:MortgageNotesBearingFixedInterestRateDueIn202020212022and2024Member
us-gaap:MortgagesMember
2018-12-31
0001574540
doc:RevolvingCreditFacilityDueSeptember2022Member
us-gaap:RevolvingCreditFacilityMember
2019-03-31
0001574540
doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
doc:MortgageNotesBearingFixedInterestRateDueIn202020212022and2024Member
us-gaap:MortgagesMember
2019-03-31
0001574540
us-gaap:MortgagesMember
2019-03-31
0001574540
doc:UnsecuredTermLoanDueJune2023Member
us-gaap:UnsecuredDebtMember
2019-03-31
0001574540
us-gaap:MortgagesMember
2018-12-31
0001574540
doc:MortgageNotesBearingVariableInterestDue2028Member
us-gaap:MortgagesMember
2019-03-31
0001574540
doc:RevolvingCreditFacilityDueSeptember2022Member
us-gaap:RevolvingCreditFacilityMember
2018-12-31
0001574540
doc:UnsecuredNotesBearingFixedInterestDueJanuary2028Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
doc:SeniorUnsecuredNotesDueAugust2025to2027Member
us-gaap:SeniorNotesMember
2018-12-31
0001574540
doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member
us-gaap:SeniorNotesMember
2018-12-31
0001574540
doc:A2018CreditAgreementAmendmentMember
2018-08-07
0001574540
srt:MaximumMember
doc:MortgageNotesBearingVariableInterestDue2028Member
us-gaap:MortgagesMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
us-gaap:InterestRateSwapMember
us-gaap:UnsecuredDebtMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-03-31
0001574540
doc:A2018CreditAgreementAmendmentMember
us-gaap:UnsecuredDebtMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
doc:SeniorNotesDue2025Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
srt:MaximumMember
doc:A2018CreditAgreementAmendmentMember
us-gaap:RevolvingCreditFacilityMember
2018-08-07
0001574540
doc:A2018CreditAgreementAmendmentMember
2019-01-01
2019-03-31
0001574540
us-gaap:LetterOfCreditMember
2019-03-31
0001574540
doc:SeniorNotesDue2023Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
doc:SeniorNotesDue2028Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
srt:MinimumMember
doc:MortgageNotesBearingFixedInterestRateDueIn202020212022and2024Member
us-gaap:MortgagesMember
2019-03-31
0001574540
us-gaap:SeniorNotesMember
2019-03-31
0001574540
doc:SenorNotesDue2031Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
doc:SeniorNotesDue2027Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
doc:A2018CreditAgreementAmendmentMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
us-gaap:InterestRateSwapMember
us-gaap:UnsecuredDebtMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2016-07-07
0001574540
doc:TermLoanMember
2016-07-07
0001574540
doc:SeniorNotesDue2026Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
us-gaap:RevolvingCreditFacilityMember
2019-03-31
0001574540
srt:MaximumMember
doc:MortgageNotesBearingFixedInterestRateDueIn202020212022and2024Member
us-gaap:MortgagesMember
2019-03-31
0001574540
doc:TermLoanMember
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RevolvingCreditFacilityMember
2019-03-31
0001574540
doc:A2018CreditAgreementAmendmentMember
doc:TermLoanMember
2018-08-07
2018-08-07
0001574540
doc:A2018CreditAgreementAmendmentMember
doc:TermLoanMember
2018-08-07
0001574540
doc:CreditratingatleastBBBplusorBAA1Member
doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastBBBorBAA2Member
doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingbelowBBBorBAA3Member
doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastBBBorBAA2Member
doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastAorA3Member
doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastBBBorBAA3Member
doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastBBBplusorBAA1Member
doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingbelowBBBorBAA3Member
doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastBBBorBAA3Member
doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
doc:CreditratingatleastAorA3Member
doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
srt:MinimumMember
doc:SeniorUnsecuredNotesDueAugust2025to2027Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
srt:MinimumMember
doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
srt:MaximumMember
doc:SeniorUnsecuredNotesDueAugust2025to2027Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
srt:MaximumMember
doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member
us-gaap:SeniorNotesMember
2019-03-31
0001574540
doc:RevolvingCreditFacilityDueSeptember2022Member
us-gaap:RevolvingCreditFacilityMember
2019-01-01
2019-03-31
0001574540
doc:UnsecuredTermLoanDueJune2023Member
us-gaap:UnsecuredDebtMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
doc:RevolvingCreditFacilityDueSeptember2022Member
us-gaap:UnsecuredDebtMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2019-01-01
2019-03-31
0001574540
us-gaap:RevolvingCreditFacilityMember
2019-01-01
2019-03-31
0001574540
us-gaap:InterestRateSwapMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2018-12-31
0001574540
us-gaap:InterestRateSwapMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-03-31
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2019-03-31
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2019-01-01
2019-03-31
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2018-12-31
0001574540
doc:PerformanceBasedRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
doc:OfficersandCertainEmployeesMember
2019-03-01
2019-03-31
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
2019-03-31
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2014-08-07
0001574540
doc:MarketConditionNumberTwoMember
doc:MarketBasedRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2019-03-01
2019-03-31
0001574540
doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2019-03-31
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
doc:TrusteesMember
2019-03-01
2019-03-31
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2014-08-07
2014-08-07
0001574540
doc:MarketBasedRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
doc:OfficersandCertainEmployeesMember
2019-03-01
2019-03-31
0001574540
doc:PerformanceBasedRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2019-03-01
2019-03-31
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
2019-01-01
2019-03-31
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2013-12-31
0001574540
doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2019-01-01
2019-03-31
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
us-gaap:DirectorMember
2019-03-31
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
doc:OfficersandCertainEmployeesMember
2019-03-01
2019-03-31
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2018-01-01
2018-03-31
0001574540
doc:TrusteeAwardsRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2019-03-31
0001574540
doc:TrusteeAwardsRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2019-01-01
2019-03-31
0001574540
doc:TrusteeAwardsRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2018-12-31
0001574540
doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2018-12-31
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
2019-03-01
2019-03-31
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
2018-01-01
2018-03-31
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
doc:TrusteesMember
2018-03-01
2018-03-31
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
doc:OfficersandCertainEmployeesMember
2018-03-01
2018-03-31
0001574540
us-gaap:FairValueMeasurementsNonrecurringMember
2019-03-31
0001574540
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2018-12-31
0001574540
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-03-31
0001574540
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0001574540
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0001574540
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2018-12-31
0001574540
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-03-31
0001574540
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-03-31
0001574540
us-gaap:InterestRateSwapMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-03-31
0001574540
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-03-31
0001574540
us-gaap:InterestRateSwapMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0001574540
doc:CHIPortfolioMember
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
2019-01-01
2019-03-31
0001574540
doc:TopfivetenantrelationshipsMember
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
2019-01-01
2019-03-31
0001574540
doc:RemainingPortfolioMember
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
2019-01-01
2019-03-31
0001574540
doc:NorthsideHospitalMember
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
2019-01-01
2019-03-31
0001574540
doc:BaylorScottandWhiteHealthMember
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
2019-01-01
2019-03-31
0001574540
doc:CHINebraskaMember
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
2019-01-01
2019-03-31
0001574540
doc:AscensionSt.VincentsIndianapolisMember
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
2019-01-01
2019-03-31
0001574540
doc:CHIKentuckyOneHealthMember
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
2019-01-01
2019-03-31
0001574540
us-gaap:SalesRevenueServicesNetMember
2019-01-01
2019-03-31
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
stpr:GA
2019-01-01
2019-03-31
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
doc:AllotherstatesMember
2019-01-01
2019-03-31
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
stpr:TX
2019-01-01
2019-03-31
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
stpr:MN
2019-01-01
2019-03-31
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
stpr:NE
2019-01-01
2019-03-31
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
stpr:IN
2019-01-01
2019-03-31
0001574540
us-gaap:RestrictedStockMember
2018-01-01
2018-03-31
0001574540
us-gaap:RestrictedStockUnitsRSUMember
2019-01-01
2019-03-31
0001574540
us-gaap:RestrictedStockMember
2019-01-01
2019-03-31
0001574540
us-gaap:RestrictedStockUnitsRSUMember
2018-01-01
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RestrictedStockMember
2018-01-01
2018-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RestrictedStockMember
2019-01-01
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RestrictedStockUnitsRSUMember
2019-01-01
2019-03-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RestrictedStockUnitsRSUMember
2018-01-01
2018-03-31
0001574540
us-gaap:SubsequentEventMember
2019-04-04
2019-04-04
0001574540
us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember
us-gaap:SubsequentEventMember
2019-04-26
2019-04-26
0001574540
us-gaap:SubsequentEventMember
2019-04-30
0001574540
us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember
us-gaap:SubsequentEventMember
2019-04-03
2019-04-03
0001574540
us-gaap:SubsequentEventMember
2019-04-04
0001574540
doc:MezzanineLoanMember
us-gaap:SubsequentEventMember
2019-04-16
doc:instruments
doc:properties
iso4217:USD
xbrli:shares
utreg:sqft
xbrli:pure
doc:segments
xbrli:shares
iso4217:USD
doc:mezzanine_loan
utreg:Rate
doc:healthcareproperty
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2019
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 001-36007 (Physicians Realty Trust)
Commission file number: 333-205034-01 (Physicians Realty L.P.)
PHYSICIANS REALTY TRUST
PHYSICIANS REALTY L.P.
(Exact Name of Registrant as Specified in its Charter)
|
| | |
Maryland (Physicians Realty Trust) Delaware (Physicians Realty L.P.) (State of Organization) | | 46-2519850 80-0941870 (IRS Employer Identification No.) |
| | |
309 N. Water Street, Suite 500 Milwaukee, Wisconsin (Address of Principal Executive Offices) | | 53202 (Zip Code) |
(414) 367-5600
(Registrant’s Telephone Number, Including Area Code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Physicians Realty Trust Yes ý No o Physicians Realty L.P. Yes ý No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Physicians Realty Trust Yes ý No o Physicians Realty L.P. Yes ý No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
| |
Physicians Realty Trust | Large accelerated filer ý Accelerated filer o Non-accelerated filer o Smaller reporting company o Emerging growth company o |
| |
Physicians Realty L.P. | Large accelerated filer o Accelerated filer o Non-accelerated filer ý Smaller reporting company o Emerging growth company o |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Physicians Realty Trust o Physicians Realty L.P. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).
Physicians Realty Trust Yes o No ý Physicians Realty L.P. Yes o No ý
The number of Physicians Realty Trust’s common shares outstanding as of April 24, 2019 was 185,281,636.
EXPLANATORY NOTE
This Quarterly Report on Form 10-Q combines the Quarterly Reports on Form 10-Q for the quarter ended March 31, 2019 of Physicians Realty Trust (the “Trust”), a Maryland real estate investment trust, and Physicians Realty L.P. (the “Operating Partnership”), a Delaware limited partnership. Unless otherwise indicated or unless the context requires otherwise, all references in this report to “we,” “us,” “our,” and the “Company,” refer to the Trust, together with its consolidated subsidiaries, including the Operating Partnership. References to the “Operating Partnership” mean collectively the Operating Partnership, together with its consolidated subsidiaries. In this report, all references to “common shares” refer to the common shares of the Trust and references to “our shareholders” refer to shareholders of the common shares of the Trust, the term “OP Units” refers to partnership interests of the Operating Partnership and the term “Series A Preferred Units” refers to Series A Participating Redeemable Preferred Units of the Operating Partnership. As of April 24, 2019, 104,172 Series A Preferred Units were outstanding.
The Trust is a self-managed real estate investment trust (“REIT”) formed primarily to acquire, selectively develop, own, and manage healthcare properties that are leased to physicians, hospitals, and healthcare delivery systems. The Trust operates in an umbrella partnership REIT structure (“UPREIT”) in which the Operating Partnership and its subsidiaries hold substantially all of the assets. The Trust’s operations are conducted through the Operating Partnership and wholly-owned and majority-owned subsidiaries of the Operating Partnership. The Trust, as the general partner of the Operating Partnership, controls the Operating Partnership and consolidates the assets, liabilities, and results of operations of the Operating Partnership.
The Trust conducts substantially all of its operations through the Operating Partnership. As of March 31, 2019, the Trust held a 97.3% interest in the Operating Partnership and owns no Series A Preferred Units. Apart from this ownership interest, the Trust has no independent operations.
Noncontrolling interests in the Operating Partnership, shareholders’ equity of the Trust, and partners’ capital of the Operating Partnership are the primary areas of difference between the consolidated financial statements of the Trust and those of the Operating Partnership. OP Units not owned by the Trust are accounted for as limited partners’ capital in the Operating Partnership’s consolidated financial statements and as noncontrolling interests in the Trust’s consolidated financial statements. The differences between the Trust’s shareholders’ equity and the Operating Partnership’s partners’ capital are due to the differences in the equity issued by the Trust and the Operating Partnership, respectively.
The Company believes combining the Quarterly Reports of the Trust and the Operating Partnership, including the notes to the consolidated financial statements, into this single report results in the following benefits:
| |
• | a combined report enhances investors’ understanding of the Trust and the Operating Partnership by enabling investors to view the business as a whole in the same manner as management views and operates the business; |
| |
• | a combined report eliminates duplicative disclosure and provides a more streamlined and readable presentation, as a substantial portion of the Company’s disclosure applies to both the Trust and the Operating Partnership; and |
| |
• | a combined report creates time and cost efficiencies through the preparation of one combined report instead of two separate reports. |
To help investors understand the significant differences between the Trust and the Operating Partnership, this report presents the following separate sections for each of the Trust and the Operating Partnership:
| |
• | the consolidated financial statements in Part I, Item 1 of this report; |
| |
• | certain accompanying notes to the consolidated financial statements, including Note 14 (Earnings Per Share and Earnings Per Unit); |
| |
• | controls and procedures in Part I, Item 4 of this report; and |
| |
• | the certifications of the Chief Executive Officer and the Chief Financial Officer included as Exhibits 31 and 32 to this report. |
PHYSICIANS REALTY TRUST AND PHYSICIANS REALTY L.P.
Quarterly Report on Form 10-Q
for the Quarter Ended March 31, 2019
Table of Contents
|
| | |
| | Page Number |
| | |
| | |
| | |
| | |
Financial Statements of Physicians Realty Trust | |
| | |
| | |
| | |
| | |
| | |
| | |
Financial Statements of Physicians Realty L.P. | |
| | |
| | |
| | |
| | |
| | |
| | |
Notes for Physicians Realty Trust and Physicians Realty L.P. | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts may be forward-looking statements within the meaning of the federal securities laws. In particular, statements pertaining to our capital resources, property performance and results of operations contain forward-looking statements. Likewise, all of our statements regarding anticipated growth in our funds from operations and anticipated market conditions, demographics and results of operations are forward-looking statements. You can identify forward-looking statements by the use of forward-looking terminology such as “believe,” “expect,” “outlook,” “continue,” “project,” “may,” “will,” “should,” “seek,” “approximately,” “intend,” “plan,” “pro forma,” “estimate” or “anticipate” or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans, expectations, or intentions.
These forward-looking statements reflect the views of our management regarding current expectations and projections about future events and are based on currently available information. These forward-looking statements are not guarantees of future performance and involve numerous risks and uncertainties and you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data, or methods which may be incorrect or imprecise and we may not be able to realize them. We do not guarantee that the transactions and events described will happen as described (or that they will happen at all). The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements:
| |
• | general economic conditions; |
| |
• | adverse economic or real estate developments, either nationally or in the markets where our properties are located; |
| |
• | our failure to generate sufficient cash flows to service our outstanding indebtedness, or our ability to pay down or refinance our indebtedness; |
| |
• | fluctuations in interest rates and increased operating costs; |
| |
• | the availability, terms and deployment of debt and equity capital, including our unsecured revolving credit facility; |
| |
• | our ability to make distributions on our common shares; |
| |
• | general volatility of the market price of our common shares;
|
| |
• | our increased vulnerability economically due to the concentration of our investments in healthcare properties; |
| |
• | our geographic concentration in Texas causes us to be particularly exposed to downturns in the Texas economy or other changes in Texas market conditions; |
| |
• | changes in our business or strategy; |
| |
• | our dependence upon key personnel whose continued service is not guaranteed; |
| |
• | our ability to identify, hire, and retain highly qualified personnel in the future;
|
| |
• | the degree and nature of our competition; |
| |
• | changes in governmental regulations or interpretations thereof, such as real estate and zoning laws and increases in real property tax rates, taxation of REITs, and similar matters; |
| |
• | defaults on or non-renewal of leases by tenants; |
| |
• | decreased rental rates or increased vacancy rates; |
| |
• | difficulties in identifying healthcare properties to acquire and completing acquisitions; |
| |
• | competition for investment opportunities; |
| |
• | any adverse effects to the business, financial position or results of CommonSpirit Health, or one or more of the CommonSpirit Health-affiliated tenants, that impact the ability of CommonSpirit Health-affiliated tenants to pay us rent; |
| |
• | the impact of our investments in joint ventures we may make in the future; |
| |
• | the financial condition and liquidity of, or disputes with, any joint venture and development partners with whom we may make co-investments in the future; |
| |
• | cybersecurity incidents could disrupt our business and result in the compromise of confidential information; |
| |
• | our ability to operate as a public company; |
| |
• | changes in healthcare laws or government reimbursement rates; |
| |
• | changes in accounting principles generally accepted in the United States (“GAAP”); |
| |
• | lack of or insufficient amounts of insurance; |
| |
• | other factors affecting the real estate industry generally; |
| |
• | our failure to maintain our qualification as a REIT for U.S. federal income tax purposes; |
| |
• | limitations imposed on our business and our ability to satisfy complex rules in order for us to qualify as a REIT for U.S. federal income tax purposes; and |
| |
• | other factors that may materially adversely affect us, or the per share trading price of our common shares, including: |
| |
• | the number of our common shares available for future issuance or sale; |
| |
• | our issuance of equity securities or the perception that such issuance might occur; |
| |
• | failure of securities analysts to publish research or reports about us or our industry; and |
| |
• | securities analysts’ downgrade of our common shares or the healthcare-related real estate sector. |
While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance. We disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events, or other changes after the date of this report, except as required by applicable law. You should not place undue reliance on any forward-looking statements that are based on information currently available to us or the third parties making the forward-looking statements. For a further discussion of these and other factors that could impact our future results, performance or transactions, see Part I, Item 1A (Risk Factors) of our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the “2018 Annual Report”).
PART I. Financial Information
Item 1. Financial Statements
Physicians Realty Trust
Consolidated Balance Sheets
(In thousands, except share and per share data)
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
| (unaudited) | | |
ASSETS | |
| | |
|
Investment properties: | |
| | |
|
Land and improvements | $ | 210,542 |
| | $ | 211,253 |
|
Building and improvements | 3,627,825 |
| | 3,623,962 |
|
Tenant improvements | 43,213 |
| | 36,497 |
|
Acquired lease intangibles | 386,707 |
| | 452,384 |
|
| 4,268,287 |
|
| 4,324,096 |
|
Accumulated depreciation | (443,814 | ) | | (411,052 | ) |
Net real estate property | 3,824,473 |
|
| 3,913,044 |
|
Real estate held for sale | 9,038 |
| | — |
|
Right-of-use lease asset, net | 126,250 |
| | — |
|
Real estate loans receivable | 75,474 |
| | 55,659 |
|
Investments in unconsolidated entities | 1,331 |
| | 1,330 |
|
Net real estate investments | 4,036,566 |
|
| 3,970,033 |
|
Cash and cash equivalents | 5,048 |
| | 19,161 |
|
Tenant receivables, net | 10,566 |
| | 8,881 |
|
Other assets | 132,825 |
| | 144,759 |
|
Total assets | $ | 4,185,005 |
|
| $ | 4,142,834 |
|
LIABILITIES AND EQUITY | |
| | |
|
Liabilities: | |
| | |
|
Credit facility | $ | 478,892 |
| | $ | 457,388 |
|
Notes payable | 967,161 |
| | 966,961 |
|
Mortgage debt | 99,608 |
| | 108,504 |
|
Accounts payable | 3,513 |
| | 3,886 |
|
Dividends and distributions payable | 44,335 |
| | 43,821 |
|
Accrued expenses and other liabilities | 56,088 |
| | 76,282 |
|
Lease liability | 60,864 |
| | — |
|
Acquired lease intangibles, net | 7,336 |
| | 13,585 |
|
Total liabilities | 1,717,797 |
|
| 1,670,427 |
|
| | | |
Redeemable noncontrolling interest - Series A Preferred Units and partially owned properties | 24,882 |
| | 24,747 |
|
| | | |
Equity: | |
| | |
|
Common shares, $0.01 par value, 500,000,000 common shares authorized, 184,307,910 and 182,416,007 common shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively | 1,843 |
| | 1,824 |
|
Additional paid-in capital | 2,822,520 |
| | 2,791,555 |
|
Accumulated deficit | (460,357 | ) | | (428,307 | ) |
Accumulated other comprehensive income | 10,957 |
| | 14,433 |
|
Total shareholders’ equity | 2,374,963 |
|
| 2,379,505 |
|
Noncontrolling interests: | |
| | |
|
Operating Partnership | 66,668 |
| | 67,477 |
|
Partially owned properties | 695 |
| | 678 |
|
Total noncontrolling interests | 67,363 |
|
| 68,155 |
|
Total equity | 2,442,326 |
|
| 2,447,660 |
|
Total liabilities and equity | $ | 4,185,005 |
|
| $ | 4,142,834 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty Trust
Consolidated Statements of Income
(In thousands, except share and per share data) (Unaudited)
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
Revenues: | |
| | |
|
Rental revenues | $ | 77,083 |
| | $ | 78,887 |
|
Expense recoveries | 26,042 |
| | 24,308 |
|
Interest income on real estate loans and other | 2,243 |
| | 2,028 |
|
Total revenues | 105,368 |
|
| 105,223 |
|
Expenses: | |
| | |
|
Interest expense | 16,269 |
| | 16,494 |
|
General and administrative | 8,972 |
| | 8,459 |
|
Operating expenses | 32,208 |
| | 30,459 |
|
Depreciation and amortization | 36,449 |
| | 38,576 |
|
Total expenses | 93,898 |
|
| 93,988 |
|
Income before equity in income of unconsolidated entities and gain on sale of investment properties, net: | 11,470 |
| | 11,235 |
|
Equity in income of unconsolidated entities | 30 |
| | 28 |
|
Gain on sale of investment properties, net | — |
| | 69 |
|
Net income | 11,500 |
|
| 11,332 |
|
Net income attributable to noncontrolling interests: | |
| | |
|
Operating Partnership | (305 | ) | | (313 | ) |
Partially owned properties (1) | (138 | ) | | (111 | ) |
Net income attributable to controlling interest | 11,057 |
|
| 10,908 |
|
Preferred distributions | (284 | ) | | (487 | ) |
Net income attributable to common shareholders | $ | 10,773 |
|
| $ | 10,421 |
|
Net income per share: | |
| | |
|
Basic | $ | 0.06 |
| | $ | 0.06 |
|
Diluted | $ | 0.06 |
| | $ | 0.06 |
|
Weighted average common shares: | |
| | |
|
Basic | 182,672,863 |
| | 181,809,570 |
|
Diluted | 188,497,308 |
| | 187,317,243 |
|
| | | |
Dividends and distributions declared per common share and OP Unit | $ | 0.23 |
| | $ | 0.23 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty Trust
Consolidated Statements of Comprehensive Income
(In thousands) (Unaudited)
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
Net income | $ | 11,500 |
| | $ | 11,332 |
|
Other comprehensive income: | | | |
Change in fair value of interest rate swap agreements, net | (3,476 | ) | | 4,298 |
|
Total other comprehensive income | (3,476 | ) | | 4,298 |
|
Comprehensive income | 8,024 |
| | 15,630 |
|
Comprehensive income attributable to noncontrolling interests - Operating Partnership | (210 | ) | | (438 | ) |
Comprehensive income attributable to noncontrolling interests - partially owned properties | (138 | ) | | (111 | ) |
Comprehensive income attributable to common shareholders | $ | 7,676 |
| | $ | 15,081 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty Trust
Consolidated Statements of Equity
(In thousands) (Unaudited)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Par Value | | Additional Paid in Capital | | Accumulated Deficit | | Accumulated Other Comprehensive Income | | Total Shareholders’ Equity | | Operating Partnership Noncontrolling Interest | | Partially Owned Properties Noncontrolling Interest | | Total Noncontrolling Interests | | Total Equity |
Balance at December 31, 2018 | $ | 1,824 |
| | $ | 2,791,555 |
| | $ | (428,307 | ) | | $ | 14,433 |
| | $ | 2,379,505 |
| | $ | 67,477 |
| | $ | 678 |
| | $ | 68,155 |
| | $ | 2,447,660 |
|
Cumulative effect of changes in accounting standard | — |
| | (239 | ) | | — |
| | — |
| | (239 | ) | | — |
| | — |
| | — |
| | (239 | ) |
Net proceeds from sale of common shares | 17 |
| | 31,003 |
| | — |
| | — |
| | 31,020 |
| | — |
| | — |
| | — |
| | 31,020 |
|
Restricted share award grants, net | 2 |
| | 640 |
| | (287 | ) | | — |
| | 355 |
| | — |
| | — |
| | — |
| | 355 |
|
Purchase of OP Units | — |
| | — |
| | — |
| | — |
| | — |
| | (105 | ) | | — |
| | (105 | ) | | (105 | ) |
Dividends/distributions declared | — |
| | — |
| | (42,536 | ) | | — |
| | (42,536 | ) | | (1,158 | ) | | — |
| | (1,158 | ) | | (43,694 | ) |
Preferred distributions | — |
| | — |
| | (284 | ) | | — |
| | (284 | ) | | — |
| | — |
| | — |
| | (284 | ) |
Distributions | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | (47 | ) | | (47 | ) | | (47 | ) |
Change in market value of Redeemable Noncontrolling Interest in Operating Partnership | — |
| | (290 | ) | | — |
| | — |
| | (290 | ) | | — |
| | — |
| | — |
| | (290 | ) |
Change in fair value of interest rate swap agreements | — |
| | — |
| | — |
| | (3,476 | ) | | (3,476 | ) | | — |
| | — |
| | — |
| | (3,476 | ) |
Net income | — |
| | — |
| | 11,057 |
| | — |
| | 11,057 |
| | 305 |
| | 64 |
| | 369 |
| | 11,426 |
|
Adjustment for Noncontrolling Interests ownership in Operating Partnership | — |
| | (149 | ) | | — |
| | — |
| | (149 | ) | | 149 |
| | — |
| | 149 |
| | — |
|
Balance at March 31, 2019 | $ | 1,843 |
| | $ | 2,822,520 |
| | $ | (460,357 | ) | | $ | 10,957 |
| | $ | 2,374,963 |
| | $ | 66,668 |
| | $ | 695 |
| | $ | 67,363 |
| | $ | 2,442,326 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty Trust
Consolidated Statements of Equity
(In thousands) (Unaudited)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Par Value | | Additional Paid in Capital | | Accumulated Deficit | | Accumulated Other Comprehensive Income | | Total Shareholders’ Equity | | Operating Partnership Noncontrolling Interest | | Partially Owned Properties Noncontrolling Interest | | Total Noncontrolling Interests | | Total Equity |
Balance at December 31, 2017 | $ | 1,814 |
| | $ | 2,772,823 |
| | $ | (315,417 | ) | | $ | 13,952 |
| | $ | 2,473,172 |
| | $ | 73,844 |
| | $ | 618 |
| | $ | 74,462 |
| | $ | 2,547,634 |
|
Net proceeds from sale of common shares | 3 |
| | 5,313 |
| | — |
| | — |
| | 5,316 |
| | — |
| | — |
| | — |
| | 5,316 |
|
Restricted share award grants, net | 2 |
| | 872 |
| | 59 |
| | — |
| | 933 |
| | — |
| | — |
| | — |
| | 933 |
|
Conversion of OP Units | — |
| | 126 |
| | — |
| | — |
| | 126 |
| | (126 | ) | | — |
| | (126 | ) | | — |
|
Dividends/distributions declared | — |
| | — |
| | (41,910 | ) | | — |
| | (41,910 | ) | | (1,216 | ) | | — |
| | (1,216 | ) | | (43,126 | ) |
Preferred distributions | — |
| | — |
| | (487 | ) | | — |
| | (487 | ) | | — |
| | — |
| | — |
| | (487 | ) |
Distributions | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | (43 | ) | | (43 | ) | | (43 | ) |
Change in market value of Redeemable Noncontrolling Interest in Operating Partnership | — |
| | 194 |
| | 1,276 |
| | — |
| | 1,470 |
| | — |
| | — |
| | — |
| | 1,470 |
|
Change in fair value of interest rate swap agreements | — |
| | — |
| | — |
| | 4,298 |
| | 4,298 |
| | — |
| | — |
| | — |
| | 4,298 |
|
Net income | — |
| | — |
| | 10,908 |
| | — |
| | 10,908 |
| | 313 |
| | 44 |
| | 357 |
| | 11,265 |
|
Adjustment for Noncontrolling Interests ownership in Operating Partnership | — |
| | (712 | ) | | — |
| | — |
| | (712 | ) | | 712 |
| | — |
| | 712 |
| | — |
|
Balance at March 31, 2018 | $ | 1,819 |
| | $ | 2,778,616 |
| | $ | (345,571 | ) | | $ | 18,250 |
| | $ | 2,453,114 |
| | $ | 73,527 |
| | $ | 619 |
| | $ | 74,146 |
| | $ | 2,527,260 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty Trust
Consolidated Statements of Cash Flows
(In thousands) (Unaudited)
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
Cash Flows from Operating Activities: | |
| | |
|
Net income | $ | 11,500 |
| | $ | 11,332 |
|
Adjustments to reconcile net income to net cash provided by operating activities | | | |
|
Depreciation and amortization | 36,449 |
| | 38,576 |
|
Amortization of deferred financing costs | 607 |
| | 618 |
|
Amortization of lease inducements and above/below-market lease intangibles | 1,176 |
| | 1,190 |
|
Straight-line rental revenue/expense | (4,762 | ) | | (6,450 | ) |
Amortization of discount on unsecured senior notes | 148 |
| | 142 |
|
Amortization of above market assumed debt | (16 | ) | | (16 | ) |
Gain on sale of investment properties, net | — |
| | (69 | ) |
Equity in income of unconsolidated entities | (30 | ) | | (28 | ) |
Distributions from unconsolidated entities | 29 |
| | 26 |
|
Change in fair value of derivative | 13 |
| | 2 |
|
Provision for bad debts | 35 |
| | (141 | ) |
Non-cash share compensation | 2,653 |
| | 2,605 |
|
Change in operating assets and liabilities: | |
| | |
|
Tenant receivables | (2,076 | ) | | 5,437 |
|
Other assets | 647 |
| | (222 | ) |
Accounts payable | (373 | ) | | (8,461 | ) |
Accrued expenses and other liabilities | (19,573 | ) | | (3,651 | ) |
Net cash provided by operating activities | 26,427 |
|
| 40,890 |
|
Cash Flows from Investing Activities: | |
| | |
|
Proceeds on sales of investment properties | — |
| | 2,440 |
|
Acquisition of investment properties, net | (4,303 | ) | | (84,202 | ) |
Escrowed cash - acquisition deposits/earnest deposits | (150 | ) | | (2,720 | ) |
Capital expenditures on investment properties | (12,953 | ) | | (5,608 | ) |
Issuance of real estate loans receivable | (20,028 | ) | | (2,000 | ) |
Repayment of real estate loans receivable | 325 |
| | 6,717 |
|
Issuance of note receivable | — |
| | (20,385 | ) |
Leasing commissions | (552 | ) | | (664 | ) |
Lease inducements | (5 | ) | | — |
|
Net cash used in investing activities | (37,666 | ) |
| (106,422 | ) |
Cash Flows from Financing Activities: | |
| | |
|
Net proceeds from sale of common shares | 31,020 |
| | 5,316 |
|
Proceeds from credit facility borrowings | 68,000 |
| | 166,000 |
|
Repayment of credit facility borrowings | (47,000 | ) | | (24,000 | ) |
Principal payments on mortgage debt | (8,908 | ) | | (32,157 | ) |
Debt issuance costs | (8 | ) | | (412 | ) |
Dividends paid - shareholders | (42,301 | ) | | (42,251 | ) |
Distributions to noncontrolling interests - Operating Partnership | (1,167 | ) | | (1,232 | ) |
Preferred distributions paid - OP Unit holder | (284 | ) | | (81 | ) |
Distributions to noncontrolling interests - partially owned properties | (148 | ) | | (127 | ) |
Payments of employee taxes for withheld stock-based compensation shares | (1,973 | ) | | (1,701 | ) |
Purchase of OP Units | (105 | ) | | — |
|
Net cash (used in) provided by financing activities | (2,874 | ) |
| 69,355 |
|
Net (decrease) increase in cash and cash equivalents | (14,113 | ) | | 3,823 |
|
Cash and cash equivalents, beginning of period | 19,161 |
| | 2,727 |
|
Cash and cash equivalents, end of period | $ | 5,048 |
|
| $ | 6,550 |
|
Supplemental disclosure of cash flow information - interest paid during the period | $ | 25,799 |
| | $ | 19,230 |
|
Supplemental disclosure of noncash activity - change in fair value of interest rate swap agreements | $ | (3,476 | ) | | $ | 4,298 |
|
Supplemental disclosure of noncash activity - issuance of OP Units and Series A Preferred Units in connection with acquisitions | $ | — |
| | $ | 22,651 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty L.P.
Consolidated Balance Sheets
(In thousands, except unit and per unit data) |
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
| (unaudited) | | |
ASSETS | |
| | |
|
Investment properties: | | | |
Land and improvements | $ | 210,542 |
| | $ | 211,253 |
|
Building and improvements | 3,627,825 |
| | 3,623,962 |
|
Tenant improvements | 43,213 |
| | 36,497 |
|
Acquired lease intangibles | 386,707 |
| | 452,384 |
|
| 4,268,287 |
| | 4,324,096 |
|
Accumulated depreciation | (443,814 | ) | | (411,052 | ) |
Net real estate property | 3,824,473 |
| | 3,913,044 |
|
Real estate held for sale | 9,038 |
| | — |
|
Right-of-use lease asset, net | 126,250 |
| | — |
|
Real estate loans receivable | 75,474 |
| | 55,659 |
|
Investments in unconsolidated entities | 1,331 |
| | 1,330 |
|
Net real estate investments | 4,036,566 |
| | 3,970,033 |
|
Cash and cash equivalents | 5,048 |
| | 19,161 |
|
Tenant receivables, net | 10,566 |
| | 8,881 |
|
Other assets | 132,825 |
| | 144,759 |
|
Total assets | $ | 4,185,005 |
| | $ | 4,142,834 |
|
LIABILITIES AND CAPITAL | | | |
Liabilities: | | | |
Credit facility | $ | 478,892 |
| | $ | 457,388 |
|
Notes payable | 967,161 |
| | 966,961 |
|
Mortgage debt | 99,608 |
| | 108,504 |
|
Accounts payable | 3,513 |
| | 3,886 |
|
Distributions payable | 44,335 |
| | 43,821 |
|
Accrued expenses and other liabilities | 56,088 |
| | 76,282 |
|
Lease liability | 60,864 |
| | — |
|
Acquired lease intangibles, net | 7,336 |
| | 13,585 |
|
Total liabilities | 1,717,797 |
| | 1,670,427 |
|
| | | |
Redeemable noncontrolling interest - Series A Preferred Units and partially owned properties | 24,882 |
| | 24,747 |
|
| | | |
Capital: | | | |
Partners’ capital: | | | |
General partners’ capital, 184,307,910 and 182,416,007 units issued and outstanding as of March 31, 2019 and December 31, 2018, respectively | 2,364,006 |
| | 2,365,072 |
|
Limited partners’ capital, 5,178,291 and 5,182,784 units issued and outstanding as of March 31, 2019 and December 31, 2018, respectively | 66,668 |
| | 67,477 |
|
Accumulated other comprehensive income | 10,957 |
| | 14,433 |
|
Total partners’ capital | 2,441,631 |
| | 2,446,982 |
|
Noncontrolling interest - partially owned properties | 695 |
| | 678 |
|
Total capital | 2,442,326 |
| | 2,447,660 |
|
Total liabilities and capital | $ | 4,185,005 |
| | $ | 4,142,834 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty L.P.
Consolidated Statements of Income
(In thousands, except unit and per unit data) (Unaudited)
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
Revenues: | |
| | |
|
Rental revenues | $ | 77,083 |
| | $ | 78,887 |
|
Expense recoveries | 26,042 |
| | 24,308 |
|
Interest income on real estate loans and other | 2,243 |
| | 2,028 |
|
Total revenues | 105,368 |
| | 105,223 |
|
Expenses: | | | |
Interest expense | 16,269 |
| | 16,494 |
|
General and administrative | 8,972 |
| | 8,459 |
|
Operating expenses | 32,208 |
| | 30,459 |
|
Depreciation and amortization | 36,449 |
| | 38,576 |
|
Total expenses | 93,898 |
| | 93,988 |
|
Income before equity in income of unconsolidated entities and gain on sale of investment properties, net: | 11,470 |
| | 11,235 |
|
Equity in income of unconsolidated entities | 30 |
| | 28 |
|
Gain on sale of investment properties, net | — |
| | 69 |
|
Net income | 11,500 |
| | 11,332 |
|
Net income attributable to noncontrolling interests - partially owned properties (1) | (138 | ) | | (111 | ) |
Net income attributable to controlling interest | 11,362 |
| | 11,221 |
|
Preferred distributions | (284 | ) | | (487 | ) |
Net income attributable to common unitholders | $ | 11,078 |
| | $ | 10,734 |
|
Net income per common unit: | | | |
Basic | $ | 0.06 |
| | $ | 0.06 |
|
Diluted | $ | 0.06 |
| | $ | 0.06 |
|
Weighted average common units: | | | |
Basic | 187,850,775 |
| | 187,264,064 |
|
Diluted | 188,497,308 |
| | 187,317,243 |
|
| | | |
Distributions declared per common unit | $ | 0.23 |
| | $ | 0.23 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty L.P.
Consolidated Statements of Comprehensive Income
(In thousands) (Unaudited)
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
Net income | $ | 11,500 |
| | $ | 11,332 |
|
Other comprehensive income: | | | |
Change in fair value of interest rate swap agreements, net | (3,476 | ) | | 4,298 |
|
Total other comprehensive income | (3,476 | ) | | 4,298 |
|
Comprehensive income | 8,024 |
| | 15,630 |
|
Comprehensive income attributable to noncontrolling interests - partially owned properties | (138 | ) | | (111 | ) |
Comprehensive income attributable to common unitholders | $ | 7,886 |
| | $ | 15,519 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty L.P.
Consolidated Statements of Changes in Capital
(In thousands) (Unaudited)
|
| | | | | | | | | | | | | | | | | | | | | | | |
| General Partner | | Limited Partner | | Accumulated Other Comprehensive Income | | Total Partners’ Capital | | Partially Owned Properties Noncontrolling Interest | | Total Capital |
Balance at December 31, 2018 | $ | 2,365,072 |
| | $ | 67,477 |
| | $ | 14,433 |
| | $ | 2,446,982 |
| | $ | 678 |
| | $ | 2,447,660 |
|
Cumulative effect of changes in accounting standard | (239 | ) | | — |
| | — |
| | (239 | ) | | — |
| | (239 | ) |
Net Proceeds from sale of Trust common shares and issuance of common units | 31,020 |
| | — |
| | — |
| | 31,020 |
| | — |
| | 31,020 |
|
Trust restricted share award grants, net | 355 |
| | — |
| | — |
| | 355 |
| | — |
| | 355 |
|
Purchase of OP Units | — |
| | (105 | ) | | — |
| | (105 | ) | | — |
| | (105 | ) |
OP Units - distributions | (42,536 | ) | | (1,158 | ) | | — |
| | (43,694 | ) | | — |
| | (43,694 | ) |
Preferred distributions | (284 | ) | | — |
| | — |
| | (284 | ) | | — |
| | (284 | ) |
Distributions | — |
| | — |
| | — |
| | — |
| | (47 | ) | | (47 | ) |
Change in market value of Redeemable Limited Partners | (290 | ) | | — |
| | — |
| | (290 | ) | | — |
| | (290 | ) |
Change in fair value of interest rate swap agreements | — |
| | — |
| | (3,476 | ) | | (3,476 | ) | | — |
| | (3,476 | ) |
Net income | 11,057 |
| | 305 |
| | — |
| | 11,362 |
| | 64 |
| | 11,426 |
|
Adjustments for Limited Partners ownership in Operating Partnership | (149 | ) | | 149 |
| | — |
| | — |
| | — |
| | — |
|
Balance at March 31, 2019 | $ | 2,364,006 |
| | $ | 66,668 |
| | $ | 10,957 |
| | $ | 2,441,631 |
| | $ | 695 |
| | $ | 2,442,326 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty L.P.
Consolidated Statements of Changes in Capital
(In thousands) (Unaudited)
|
| | | | | | | | | | | | | | | | | | | | | | | |
| General Partner | | Limited Partner | | Accumulated Other Comprehensive Income | | Total Partners’ Capital | | Partially Owned Properties Noncontrolling Interest | | Total Capital |
Balance at December 31, 2017 | $ | 2,459,220 |
| | $ | 73,844 |
| | $ | 13,952 |
| | $ | 2,547,016 |
| | $ | 618 |
| | $ | 2,547,634 |
|
Net Proceeds from sale of Trust common shares and issuance of common units | 5,316 |
| | — |
| | — |
| | 5,316 |
| | — |
| | 5,316 |
|
Trust restricted share award grants, net | 933 |
| | — |
| | — |
| | 933 |
| | — |
| | 933 |
|
Conversion of OP Units | 126 |
| | |